Insider · CIK 0001714564
Todd Shegog
Files at COGT (Cogent Biosciences, Inc.). First filing -, latest -.
Todd Shegog files SEC Form 4 as director at COGT (Cogent Biosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Todd Shegog has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | COGT Cogent Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +17,901 | $0.00 | $0 | 17,901 | Jun 11, 2026 |
| Jun 4, 2025 | COGT Cogent Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +44,700 | $0.00 | $0 | 44,700 | Jun 5, 2025 |
Questions about Todd Shegog
Answered from the filings on this page, as of the latest one.
Is Todd Shegog buying or selling?
Todd Shegog has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Todd Shegog's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Todd Shegog has 0.
Where does Todd Shegog file Form 4?
Todd Shegog has filed Form 4 at COGT (Cogent Biosciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.